Tuberous Sclerosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Feasibility of [11C]Acetate-Positron Emission Tomography (PET) in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
Conditions:   Lymphangioleiomyomatosis Sporadic;   Lymphangioleiomyomatosis Associated With Tuberous Sclerosis Complex Intervention:   Drug: [11C]acetate Sponsors:   Brigham and Women's Hospital;   Massachusetts General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials

Feasibility of [11C]Acetate-Positron Emission Tomography (PET) in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex
Conditions:   Lymphangioleiomyomatosis;   Tuberous Sclerosis Complex Intervention:   Drug: [11C]acetate Sponsors:   Brigham and Women's Hospital;   Massachusetts General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials